28
https://pubmed.ncbi.nlm.nih.gov/38115011
The study suggests that FGF14 may be a potential therapeutic target for mitigating the consequences of TNF-mediated neuroinflammation in cerebral malaria.
“FGF14 as a Potential Therapeutic Target for TNF-Mediated Neuroinflammation in Cerebral Malaria: A Study Suggests”
